MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14283/jpad.2022.77

Медицинская библиотека · The journal of prevention of Alzheimer's disease · 2022

Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies.

Adesuyan M, Jani Y H, Alsugeir D, Cheung E C L, Chui C S L, Howard R, Wong I C K, Brauer R

МетаанализСистематический обзорСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Hypertension is a recognized risk factor for dementia. However, evidence for using antihypertensive agents to reduce the risk of Alzheimer's disease in people with hypertension is inconclusive.

OBJECTIVE

To examine the association between antihypertensive agents and the incidence of Alzheimer's disease in adults with hypertension and normal cognition.

DESIGN

We conducted a systemic review and performed meta-analyses using Ovid MEDLINE, Ovid Embase, Ovid PsycINFO, Web of science and Scopus, from inception to 18th February 2022.

SETTING

Cohort and case-control studies.

PARTICIPANTS

Adults ≥ 40 years with hypertension and normal cognition.

INTERVENTION: Antihypertensive agents.

MEASUREMENTS: We performed two separate meta-analyses, pooling the adjusted relative risk (RR) of non-antihypertensive comparator and antihypertensive comparator study design.

RESULTS

We included nine studies, totalling 1,527,410 individuals. Meta-analysis of non-antihypertensive user comparator studies found that the use of antihypertensive agents is associated with a reduced risk of incident Alzheimer's disease (RR= 0.94, 95% CI 0.90-0.99; p=0.01). Meta-analysis of antihypertensive comparator studies found evidence that angiotensin II receptor blocker users are associated with a reduction in the risk of Alzheimer's disease compared to other antihypertensive agents (RR= 0.78, 95% CI 0.68-0.88; p< 0.001).

CONCLUSION

Our review provides evidence that the use of antihypertensive agents is associated with a lower incidence of Alzheimer's disease. The use of angiotensin II receptor blockers may provide the most benefit among antihypertensive agents. Lowering raised blood pressure may not be the only mechanism for cognitive protection and further investigation of the effects of angiotensin II on cognition is indicated.

Для цитирования: Adesuyan M, Jani Y H, Alsugeir D, Cheung E C L, Chui C S L, Howard R, Wong I C K, Brauer R. Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies.. The journal of prevention of Alzheimer's disease. 2022. DOI: 10.14283/jpad.2022.77.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.